INSAN, Inc.

INSAN, Inc.

KKRX:277410
5,220.00
KRW
-20.00
(-0.38%)
656.44EPS
11.95P/E
30.20BMarket Cap
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
295,833.13
11,992.27
9,998.72
11,515.93
12,654.18
10,399.96
10,583.44
8,418.66
9,341.1
13,535.11
Basic EPS, GAAP
36,258.45
-452.02
1,210
1,770
2,090
1,110
1,410
230
170
669.33
Free Cash Flow per Basic Share
25,244.39
447.07
-727.5
-3,606.91
-883.25
-3,550.55
1,158.78
-3,680.07
-4,776.01
-4,888.77
Dividend per Share
1,432.52
160.9
188.87
300.11
437.59
794.91
367.03
496.46
196.68
258.07
Book Value per Share
60,295.68
9,854.92
11,558.24
13,034.87
15,556
15,778.7
17,128.89
17,318.28
17,286.21
17,510.98
Tangible Book Value per Share
57,717.93
9,636.98
11,424.84
12,931.82
15,513.08
15,741.58
17,104.75
17,294.43
17,252.21
17,482.22
Basic Weighted Avg Shares
- -
2
3
3
3
3
4
4
4
3
Sales/Revenue/Turnover
26,018
25,232
25,864
30,465
38,308
33,538
37,300
32,484
35,804
39,595
Operating Margin (%)
17.42
16.71
15.44
18.75
21.48
14.03
15.39
2.5
6.44
5.04
Depreciation Expense
888
939
1,677
1,771
2,023
1,984
2,097
2,030
2,063
2,055
Net Income, GAAP
3,189
-951
3,130
4,682
6,327
3,580
4,969
887
652
1,958
Effective Tax Rate (%)
20.25
- -
19.35
14.16
16.81
6.24
19.98
10.6
27.31
27.12
Profit Margin (%)
12.26
-3.77
12.1
15.37
16.52
10.67
13.32
2.73
1.82
4.95
Working Capital
4,039
8,088
18,764
9,483
25,604
14,881
17,810
16,625
-12,178
-4,966
LT Debt
6,388
2,356
10,503
12,143
22,106
21,384
8,793
20,178
12,120
18,584
Total Equity
13,438
24,207
30,746
34,771
50,151
51,355
65,956
65,607
65,566
66,399
Return on Invested Capital (%)
- -
- -
8.25
9.13
9.62
5.41
5.48
0.8
1.64
1.4
Return on Capital (%)
- -
- -
8.15
9.05
9.5
4.98
5.98
1.33
0.81
1.94
Return on Common Equity (%)
- -
-5.09
11.45
14.38
15
7.1
8.52
1.36
1
3.02

Capital Structure

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
30,108
31,608
23,244
LT Borrowings
11,943
11,587
18,413
LT Finance Leases
177
115
171
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
4
4
4
Market Capitalization
45,939
42,013
30,198

Working Capital

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
23,861
23,305
25,575
Cash, Cash Equivalents & STI
3,196
2,229
4,528
Accounts Receivable, Net
654
1,014
549
Inventories
19,323
19,391
19,419
Total Current Liabilities
36,040
39,612
30,541
Payables & Accruals
- -
- -
- -
ST Debt
30,108
31,608
23,244
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
14.89%
-0.06%
Free Cash Flow
- -
-59.64%
28.92%
Net Income, GAAP
- -
-15.64%
-26.58%
Sales/Revenue/Turnover
- -
4.36%
10.22%
Total Cash Common Dividend
- -
19.65%
-60.65%

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
7,340
7,817
9,355
7,972
32,484
2025
7,582
8,535
10,937
8,750
35,804
2026
9,990
9,918
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-120
20
20
313.85
230
2025
-70
-1,340
328.29
47.41
170
2026
-87.91
2,310
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
496.46
2025
200.57
- -
- -
- -
196.68
2026
200
- -
- -
- -
- -

Company Description

CEO
Yoon-Se Kim
Full Time Employees
199
Sector
Consumer non-durables
Industry
Food: major diversified
Address
Hamyang-gun South Korea
IPO Date
Sep 29, 2017
Business
INSAN, Inc. is a South Korea-based health food and wellness company specializing in the research, manufacturing, and commercial distribution of traditional Korean bamboo salt and bamboo salt-derived functional health products. Founded in 1987 and headquartered in Hamyang-gun, Gyeongsangnam-do, South Korea, the company operates across specialized health functional foods, traditional fermented condiments, personal care, and wellness hospitality sectors. The company's core product and service portfolio comprises: Bamboo Salt Products, including nine-times baked purple bamboo salt, three-times baked salt, powdered and granular table salts, and mineral-enhanced cooking salts; Traditional Fermented Condiments, including bamboo salt-infused soybean paste (doenjang), traditional soy sauce (ganjang), and red pepper paste (gochujang); Health and Dietary Supplements, featuring safflower seed powder and extract tablets, sulfur-fed duck extract, marsh snail extract, walnut oil essence, garlic-bamboo salt pills, and functional botanical health drinks; Personal Care and Hygiene Formulations, encompassing bamboo salt toothpaste, natural soaps, body cleansers, and topical skincare items; and Wellness and Tourism Services, comprising customized health retreat camps, dietary lifestyle education programs, and health tours operated through the Insan Training Institute. INSAN, Inc. serves retail consumers, direct-member networks, and commercial clients across South Korea through direct flagship branches, online commerce platforms, and home shopping channels, while distributing internationally to markets including the United States, Japan, China, and Southeast Asia. In recent operational developments, the company completed construction and secured administrative operational approval for its state-of-the-art automated smart factory within the Insan Bamboo Salt Anti-Aging Regional Specialized Agro-Industrial Complex in Hamyang, expanding manufacturing capacity more than fourfold to accelerate global exports and scale business-to-business OEM and ODM partnerships. The company is advancing a multi-year project to expand the site into an integrated wellness and industrial tourism destination featuring a dedicated bamboo salt museum, educational facilities, cultural centers, and accommodation amenities, financed through strategic capital raises and equity adjustments on the KOSDAQ market.